
A filter, not a formality: BVI derivative action leave after Dekel Derivative action or unfair prejudice? The leave requirement under section 184C of the BCA A realistic prospect of success Practical lessons Comment
A BVI derivative action lets a minority shareholder sue on behalf of the company when those in control will not, but leave is far from automatic. The Court of Appeal's recent decision in Dekel v Clerkenwell Lifestyle Ltd is a timely reminder of how high the bar is. It also provides a good opportunity to recap how the derivative route differs from the more familiar unfair prejudice claim. Minority shareholders who are unhappy with how a BVI company is run usually have two main statutory options under the BVI Business Companies Act, Revised Edition 2020 (BCA). An unfair prejudice claim (governed by s184I of the BCA) is a personal claim: the shareholder complains that the company's affairs have been conducted in a way that is unfairly prejudicial to them as a member, and the court has wide powers to remedy that, often by ordering a buy-out. A derivative action is different. The claim belongs to the company, the shareholder is simply the vehicle for bringing it, and any recovery goes to the company rather than to the shareholder personally. That distinction matters. Where directors have caused loss to the company itself, for example through breaches of duty, conflicted transactions or diverting value to connected parties, the shareholder's own loss will usually just reflect the company's loss. The reflective loss rule, as explained in the UK Supreme Court case of Sevilleja v Marex, generally prevents a shareholder recovering that loss in its own name. In that situation the derivative action is often the only way to get the claim in front of a court. A shareholder cannot bring a derivative claim without the court's leave under section 184C of the BCA. The power is discretionary and the court must consider a series of statutory factors, including: whether the member is acting in good faith; whether the proceedings are in the company's interests taking account of the views of the company's directors on commercial matters; whether the proceedings are likely to succeed; the costs of the proceedings compared with the relief likely to be obtained; and whether an alternative remedy to the derivative claim is available. The availability of an alternative remedy is where the two routes meet. If the shareholder's complaint can properly be addressed through an unfair prejudice claim, that may weigh against leave for a derivative action, although the Court of Appeal in Dekel did not rule on this point. The judge did, however, take the parallel English proceedings and the availability of alternative remedies into account. Although there is no strict merits threshold, the court must be satisfied, on an evaluative assessment of the evidence, that the proposed claim has a realistic prospect of success. The Court of Appeal endorsed the judge's approach. In Dekel, a shareholder in a BVI holding company that had raised investor funds for a failed London hotel development sought leave to sue directors, service providers and connected lenders in proceedings in England and Wales. He had invested about £4 million, of which about £2.8 million was lost. The BVI Commercial Court refused leave, and the Court of Appeal upheld that decision. The decision in Dekel gives several practical lessons for shareholders considering this route: Dishonesty needs evidence. Dishonesty is rarely proved directly at an early stage, but conflicts of interest, related-party loans and expensive financing will often be consistent with commercial decisions that went wrong. Without primary facts capable of supporting an inference of dishonesty, the claim will not get off the ground. A failed project is not negligence. The shareholder must show why decisions were negligent when they were made, not just unsuccessful in hindsight, and link the breach to identifiable loss. Check the company's articles. An indemnity in the articles that mirrors section 132 of the BCA can give directors a broad defence to non-fraudulent claims, including claims brought derivatively in the company's na...







